Scotiabank Assumes Thomson Reuters at Sector Perform, Announces Price Target of $126
Scotiabank analyst Maher Yaghi assumes Thomson Reuters (NYSE:TRI) with a Sector Perform rating and announces Price Target of $126.
William Blair Initiates Coverage On NewAmsterdam Pharma with Outperform Rating
William Blair analyst Matthew Phipps initiates coverage on NewAmsterdam Pharma (NASDAQ:NAMS) with a Outperform rating.
EF Hutton Initiates Coverage On Acasti Pharma with Buy Rating, Announces Price Target of $2.5
EF Hutton analyst Constantine Davides initiates coverage on Acasti Pharma (NASDAQ:ACST) with a Buy rating and announces Price Target of $2.5.
EF Hutton Initiates Coverage On Pineapple Energy with Buy Rating, Announces Price Target of $5.5
EF Hutton analyst Chip Moore initiates coverage on Pineapple Energy (NASDAQ:PEGY) with a Buy rating and announces Price Target of $5.5.
Jefferies Initiates Coverage On NewAmsterdam Pharma with Buy Rating, Announces Price Target of $24
Jefferies analyst Dennis Ding initiates coverage on NewAmsterdam Pharma (NASDAQ:NAMS) with a Buy rating and announces Price Target of $24.
Barclays Initiates Coverage On F&G Annuities & Life with Equal-Weight Rating, Announces Price Target of $22
Barclays analyst Mark Devries initiates coverage on F&G Annuities & Life (NYSE:FG) with a Equal-Weight rating and announces Price Target of $22.
Cowen & Co. Initiates Coverage On DZS with Outperform Rating, Announces Price Target of $25
Cowen & Co. analyst Paul Silverstein initiates coverage on DZS (NASDAQ:DZSI) with a Outperform rating and announces Price Target of $25.
JonesTrading Initiates Coverage On Annaly Capital Management with Buy Rating, Announces Price Target of $22.5
JonesTrading analyst Jason Stewart initiates coverage on Annaly Capital Management (NYSE:NLY) with a Buy rating and announces Price Target of $22.5.
Goldman Sachs Initiates Coverage On Ventyx Biosciences with Buy Rating, Announces Price Target of $50
Goldman Sachs analyst Chris Shibutani initiates coverage on Ventyx Biosciences (NASDAQ:VTYX) with a Buy rating and announces Price Target of $50.
Why This Alight Analyst Says Company Is ‘Recession-Resilient’
Shares of Alight Inc (NYSE: ALIT) fell sharply in the premarket session on Friday — but the valuation of the stock does not reflect the company’s “recession-resilient business model” and potential to generate 16% EPS growth, a